Jim Simons Axsome Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$68.34 - $85.84 $4.54 Million - $5.7 Million	-66,400 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$49.87 - $98.69 $713,141 - $1.41 Million	14,300 Added 27.45%	66,400 $5.46 Million
Q1 2020 May 14, 2020	BUY	$41.2 - $101.31 $54,796 - $134,742	1,330 Added 2.62%	52,100 $3.07 Million
Q4 2019 Feb 13, 2020	BUY	$16.71 - $106.24 $848,366 - $5.39 Million	50,770 New	50,770 $5.25 Million
Q3 2019 Nov 13, 2019	SELL	$20.24 - $29.16 $5 Million - $7.21 Million	-247,200 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$13.46 - $25.75 $3.33 Million - $6.37 Million	247,200 New	247,200 $6.37 Million
Q1 2019 May 14, 2019	SELL	$2.63 - $16.34 $39,739 - $246,897	-15,110 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$2.0 - $4.15 $30,220 - $62,706	15,110 New	15,110 $43,000

289

40.5M

365K

428K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.61B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.